 | • レポートコード：MRC2Q12-17028 • 出版社/出版日：QYResearch / 2022年12月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、78ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥710,500 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,421,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、生体吸収性眼科用薬物送達システムのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 生体吸収性眼科用薬物送達システムのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生体吸収性眼科用薬物送達システムの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生体吸収性眼科用薬物送達システムのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの生体吸収性眼科用薬物送達システムの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の生体吸収性眼科用薬物送達システムの売上および2028年までの予測に焦点を当てています。 生体吸収性眼科用薬物送達システムのグローバル主要企業には、Boehringer Ingelheim、Allergan、Re-Vana Therapeutics、PolyActivaなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 生体吸収性眼科用薬物送達システム市場は、タイプとアプリケーションによって区分されます。世界の生体吸収性眼科用薬物送達システム市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 前方薬物送達法、後方薬物送達法 【アプリケーション別セグメント】 病院、診療所、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 生体吸収性眼科用薬物送達システム製品概要 - タイプ別市場（前方薬物送達法、後方薬物送達法） - アプリケーション別市場（病院、診療所、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の生体吸収性眼科用薬物送達システム販売量予測2017-2028 - 世界の生体吸収性眼科用薬物送達システム売上予測2017-2028 - 生体吸収性眼科用薬物送達システムの地域別販売量 - 生体吸収性眼科用薬物送達システムの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別生体吸収性眼科用薬物送達システム販売量 - 主要メーカー別生体吸収性眼科用薬物送達システム売上 - 主要メーカー別生体吸収性眼科用薬物送達システム価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（前方薬物送達法、後方薬物送達法） - 生体吸収性眼科用薬物送達システムのタイプ別販売量 - 生体吸収性眼科用薬物送達システムのタイプ別売上 - 生体吸収性眼科用薬物送達システムのタイプ別価格 ・アプリケーション別市場規模（病院、診療所、その他） - 生体吸収性眼科用薬物送達システムのアプリケーション別販売量 - 生体吸収性眼科用薬物送達システムのアプリケーション別売上 - 生体吸収性眼科用薬物送達システムのアプリケーション別価格 ・北米市場 - 北米の生体吸収性眼科用薬物送達システム市場規模（タイプ別、アプリケーション別） - 主要国別の生体吸収性眼科用薬物送達システム市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの生体吸収性眼科用薬物送達システム市場規模（タイプ別、アプリケーション別） - 主要国別の生体吸収性眼科用薬物送達システム市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の生体吸収性眼科用薬物送達システム市場規模（タイプ別、アプリケーション別） - 主要国別の生体吸収性眼科用薬物送達システム市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の生体吸収性眼科用薬物送達システム市場規模（タイプ別、アプリケーション別） - 主要国別の生体吸収性眼科用薬物送達システム市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの生体吸収性眼科用薬物送達システム市場規模（タイプ別、アプリケーション別） - 主要国別の生体吸収性眼科用薬物送達システム市場規模（トルコ、サウジアラビア） ・企業情報 Boehringer Ingelheim、Allergan、Re-Vana Therapeutics、PolyActiva ・産業チェーン及び販売チャネル分析 - 生体吸収性眼科用薬物送達システムの産業チェーン分析 - 生体吸収性眼科用薬物送達システムの原材料 - 生体吸収性眼科用薬物送達システムの生産プロセス - 生体吸収性眼科用薬物送達システムの販売及びマーケティング - 生体吸収性眼科用薬物送達システムの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 生体吸収性眼科用薬物送達システムの産業動向 - 生体吸収性眼科用薬物送達システムのマーケットドライバー - 生体吸収性眼科用薬物送達システムの課題 - 生体吸収性眼科用薬物送達システムの阻害要因 ・主な調査結果 |
Bioresorbable implants are inserted into the patient’s eye and safely absorbed by the body over time.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Bioresorbable Ophthalmic Drug Delivery System is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Bioresorbable Ophthalmic Drug Delivery System is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Bioresorbable Ophthalmic Drug Delivery System is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Bioresorbable Ophthalmic Drug Delivery System include Boehringer Ingelheim, Allergan, Re-Vana Therapeutics and PolyActiva, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Bioresorbable Ophthalmic Drug Delivery System manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Bioresorbable Ophthalmic Drug Delivery System market. Further, it explains the major drivers and regional dynamics of the global Bioresorbable Ophthalmic Drug Delivery System market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Boehringer Ingelheim
Allergan
Re-Vana Therapeutics
PolyActiva
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Bioresorbable Ophthalmic Drug Delivery System Segment by Type
Anterior Drug Delivery Methods
Posterior Drug Delivery Methods
Bioresorbable Ophthalmic Drug Delivery System Segment by Application
Hospitals
Clinics
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Bioresorbable Ophthalmic Drug Delivery System market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Bioresorbable Ophthalmic Drug Delivery System, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Bioresorbable Ophthalmic Drug Delivery System, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Bioresorbable Ophthalmic Drug Delivery System, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Bioresorbable Ophthalmic Drug Delivery System sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Bioresorbable Ophthalmic Drug Delivery System market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Bioresorbable Ophthalmic Drug Delivery System sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Boehringer Ingelheim, Allergan, Re-Vana Therapeutics and PolyActiva, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Bioresorbable Ophthalmic Drug Delivery System in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Bioresorbable Ophthalmic Drug Delivery System manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Bioresorbable Ophthalmic Drug Delivery System sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Bioresorbable Ophthalmic Drug Delivery System Product Introduction
1.2 Market by Type
1.2.1 Global Bioresorbable Ophthalmic Drug Delivery System Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Anterior Drug Delivery Methods
1.2.3 Posterior Drug Delivery Methods
1.3 Market by Application
1.3.1 Global Bioresorbable Ophthalmic Drug Delivery System Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Bioresorbable Ophthalmic Drug Delivery System Sales Estimates and Forecasts 2017-2028
2.2 Global Bioresorbable Ophthalmic Drug Delivery System Revenue Estimates and Forecasts 2017-2028
2.3 Global Bioresorbable Ophthalmic Drug Delivery System Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Bioresorbable Ophthalmic Drug Delivery System Sales by Region
2.4.1 Global Bioresorbable Ophthalmic Drug Delivery System Sales by Region (2017-2022)
2.4.2 Global Sales Bioresorbable Ophthalmic Drug Delivery System by Region (2023-2028)
2.5 Global Bioresorbable Ophthalmic Drug Delivery System Revenue by Region
2.5.1 Global Bioresorbable Ophthalmic Drug Delivery System Revenue by Region (2017-2022)
2.5.2 Global Bioresorbable Ophthalmic Drug Delivery System Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Bioresorbable Ophthalmic Drug Delivery System Sales by Manufacturers
3.1.1 Global Top Bioresorbable Ophthalmic Drug Delivery System Manufacturers by Sales (2017-2022)
3.1.2 Global Bioresorbable Ophthalmic Drug Delivery System Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Bioresorbable Ophthalmic Drug Delivery System in 2021
3.2 Global Bioresorbable Ophthalmic Drug Delivery System Revenue by Manufacturers
3.2.1 Global Bioresorbable Ophthalmic Drug Delivery System Revenue by Manufacturers (2017-2022)
3.2.2 Global Bioresorbable Ophthalmic Drug Delivery System Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Bioresorbable Ophthalmic Drug Delivery System Revenue in 2021
3.3 Global Bioresorbable Ophthalmic Drug Delivery System Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Bioresorbable Ophthalmic Drug Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Bioresorbable Ophthalmic Drug Delivery System Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Bioresorbable Ophthalmic Drug Delivery System Sales by Type
4.1.1 Global Bioresorbable Ophthalmic Drug Delivery System Historical Sales by Type (2017-2022)
4.1.2 Global Bioresorbable Ophthalmic Drug Delivery System Forecasted Sales by Type (2023-2028)
4.1.3 Global Bioresorbable Ophthalmic Drug Delivery System Sales Market Share by Type (2017-2028)
4.2 Global Bioresorbable Ophthalmic Drug Delivery System Revenue by Type
4.2.1 Global Bioresorbable Ophthalmic Drug Delivery System Historical Revenue by Type (2017-2022)
4.2.2 Global Bioresorbable Ophthalmic Drug Delivery System Forecasted Revenue by Type (2023-2028)
4.2.3 Global Bioresorbable Ophthalmic Drug Delivery System Revenue Market Share by Type (2017-2028)
4.3 Global Bioresorbable Ophthalmic Drug Delivery System Price by Type
4.3.1 Global Bioresorbable Ophthalmic Drug Delivery System Price by Type (2017-2022)
4.3.2 Global Bioresorbable Ophthalmic Drug Delivery System Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Bioresorbable Ophthalmic Drug Delivery System Sales by Application
5.1.1 Global Bioresorbable Ophthalmic Drug Delivery System Historical Sales by Application (2017-2022)
5.1.2 Global Bioresorbable Ophthalmic Drug Delivery System Forecasted Sales by Application (2023-2028)
5.1.3 Global Bioresorbable Ophthalmic Drug Delivery System Sales Market Share by Application (2017-2028)
5.2 Global Bioresorbable Ophthalmic Drug Delivery System Revenue by Application
5.2.1 Global Bioresorbable Ophthalmic Drug Delivery System Historical Revenue by Application (2017-2022)
5.2.2 Global Bioresorbable Ophthalmic Drug Delivery System Forecasted Revenue by Application (2023-2028)
5.2.3 Global Bioresorbable Ophthalmic Drug Delivery System Revenue Market Share by Application (2017-2028)
5.3 Global Bioresorbable Ophthalmic Drug Delivery System Price by Application
5.3.1 Global Bioresorbable Ophthalmic Drug Delivery System Price by Application (2017-2022)
5.3.2 Global Bioresorbable Ophthalmic Drug Delivery System Price Forecast by Application (2023-2028)
6 North America
6.1 North America Bioresorbable Ophthalmic Drug Delivery System Market Size by Type
6.1.1 North America Bioresorbable Ophthalmic Drug Delivery System Sales by Type (2017-2028)
6.1.2 North America Bioresorbable Ophthalmic Drug Delivery System Revenue by Type (2017-2028)
6.2 North America Bioresorbable Ophthalmic Drug Delivery System Market Size by Application
6.2.1 North America Bioresorbable Ophthalmic Drug Delivery System Sales by Application (2017-2028)
6.2.2 North America Bioresorbable Ophthalmic Drug Delivery System Revenue by Application (2017-2028)
6.3 North America Bioresorbable Ophthalmic Drug Delivery System Market Size by Country
6.3.1 North America Bioresorbable Ophthalmic Drug Delivery System Sales by Country (2017-2028)
6.3.2 North America Bioresorbable Ophthalmic Drug Delivery System Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Bioresorbable Ophthalmic Drug Delivery System Market Size by Type
7.1.1 Europe Bioresorbable Ophthalmic Drug Delivery System Sales by Type (2017-2028)
7.1.2 Europe Bioresorbable Ophthalmic Drug Delivery System Revenue by Type (2017-2028)
7.2 Europe Bioresorbable Ophthalmic Drug Delivery System Market Size by Application
7.2.1 Europe Bioresorbable Ophthalmic Drug Delivery System Sales by Application (2017-2028)
7.2.2 Europe Bioresorbable Ophthalmic Drug Delivery System Revenue by Application (2017-2028)
7.3 Europe Bioresorbable Ophthalmic Drug Delivery System Market Size by Country
7.3.1 Europe Bioresorbable Ophthalmic Drug Delivery System Sales by Country (2017-2028)
7.3.2 Europe Bioresorbable Ophthalmic Drug Delivery System Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Bioresorbable Ophthalmic Drug Delivery System Market Size by Type
8.1.1 Asia Pacific Bioresorbable Ophthalmic Drug Delivery System Sales by Type (2017-2028)
8.1.2 Asia Pacific Bioresorbable Ophthalmic Drug Delivery System Revenue by Type (2017-2028)
8.2 Asia Pacific Bioresorbable Ophthalmic Drug Delivery System Market Size by Application
8.2.1 Asia Pacific Bioresorbable Ophthalmic Drug Delivery System Sales by Application (2017-2028)
8.2.2 Asia Pacific Bioresorbable Ophthalmic Drug Delivery System Revenue by Application (2017-2028)
8.3 Asia Pacific Bioresorbable Ophthalmic Drug Delivery System Market Size by Region
8.3.1 Asia Pacific Bioresorbable Ophthalmic Drug Delivery System Sales by Region (2017-2028)
8.3.2 Asia Pacific Bioresorbable Ophthalmic Drug Delivery System Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Bioresorbable Ophthalmic Drug Delivery System Market Size by Type
9.1.1 Latin America Bioresorbable Ophthalmic Drug Delivery System Sales by Type (2017-2028)
9.1.2 Latin America Bioresorbable Ophthalmic Drug Delivery System Revenue by Type (2017-2028)
9.2 Latin America Bioresorbable Ophthalmic Drug Delivery System Market Size by Application
9.2.1 Latin America Bioresorbable Ophthalmic Drug Delivery System Sales by Application (2017-2028)
9.2.2 Latin America Bioresorbable Ophthalmic Drug Delivery System Revenue by Application (2017-2028)
9.3 Latin America Bioresorbable Ophthalmic Drug Delivery System Market Size by Country
9.3.1 Latin America Bioresorbable Ophthalmic Drug Delivery System Sales by Country (2017-2028)
9.3.2 Latin America Bioresorbable Ophthalmic Drug Delivery System Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Bioresorbable Ophthalmic Drug Delivery System Market Size by Type
10.1.1 Middle East and Africa Bioresorbable Ophthalmic Drug Delivery System Sales by Type (2017-2028)
10.1.2 Middle East and Africa Bioresorbable Ophthalmic Drug Delivery System Revenue by Type (2017-2028)
10.2 Middle East and Africa Bioresorbable Ophthalmic Drug Delivery System Market Size by Application
10.2.1 Middle East and Africa Bioresorbable Ophthalmic Drug Delivery System Sales by Application (2017-2028)
10.2.2 Middle East and Africa Bioresorbable Ophthalmic Drug Delivery System Revenue by Application (2017-2028)
10.3 Middle East and Africa Bioresorbable Ophthalmic Drug Delivery System Market Size by Country
10.3.1 Middle East and Africa Bioresorbable Ophthalmic Drug Delivery System Sales by Country (2017-2028)
10.3.2 Middle East and Africa Bioresorbable Ophthalmic Drug Delivery System Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Corporation Information
11.1.2 Boehringer Ingelheim Overview
11.1.3 Boehringer Ingelheim Bioresorbable Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Boehringer Ingelheim Bioresorbable Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Boehringer Ingelheim Recent Developments
11.2 Allergan
11.2.1 Allergan Corporation Information
11.2.2 Allergan Overview
11.2.3 Allergan Bioresorbable Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Allergan Bioresorbable Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Allergan Recent Developments
11.3 Re-Vana Therapeutics
11.3.1 Re-Vana Therapeutics Corporation Information
11.3.2 Re-Vana Therapeutics Overview
11.3.3 Re-Vana Therapeutics Bioresorbable Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Re-Vana Therapeutics Bioresorbable Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Re-Vana Therapeutics Recent Developments
11.4 PolyActiva
11.4.1 PolyActiva Corporation Information
11.4.2 PolyActiva Overview
11.4.3 PolyActiva Bioresorbable Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 PolyActiva Bioresorbable Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 PolyActiva Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Bioresorbable Ophthalmic Drug Delivery System Industry Chain Analysis
12.2 Bioresorbable Ophthalmic Drug Delivery System Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Bioresorbable Ophthalmic Drug Delivery System Production Mode & Process
12.4 Bioresorbable Ophthalmic Drug Delivery System Sales and Marketing
12.4.1 Bioresorbable Ophthalmic Drug Delivery System Sales Channels
12.4.2 Bioresorbable Ophthalmic Drug Delivery System Distributors
12.5 Bioresorbable Ophthalmic Drug Delivery System Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Bioresorbable Ophthalmic Drug Delivery System Industry Trends
13.2 Bioresorbable Ophthalmic Drug Delivery System Market Drivers
13.3 Bioresorbable Ophthalmic Drug Delivery System Market Challenges
13.4 Bioresorbable Ophthalmic Drug Delivery System Market Restraints
14 Key Findings in The Global Bioresorbable Ophthalmic Drug Delivery System Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
| 【生体吸収性眼科用薬物送達システムについて】 生体吸収性眼科用薬物送達システムは、眼科領域で使用される薬物を効率的に投与するための革新的な技術です。このシステムは、生体内で吸収される材料を使用し、患者の不快感を軽減しながら持続的に薬物を供給することが可能です。眼科用薬物送達は、従来の点眼薬や注射に比べて、より効果的かつ安全な治療法を提供することを目指しています。 このシステムの主な特徴は、生体吸収性の材料を用いることで、医療機器や薬物が体内に残ることなく、自然に分解される点です。そのため、患者の治療後のケアが容易になり、副作用のリスクも軽減されます。また、薬物が持続的に放出される設計により、頻繁な投与を必要とせず、患者のQOL（生活の質）の向上にも寄与します。 生体吸収性眼科用薬物送達システムには、大きく分けてポリマー系とナノ粒子系の二つのタイプがあります。ポリマー系は、ポリ乳酸（PLA）、ポリグリコール酸（PGA）およびその共重合体などがよく使用される材料です。これらは生体内で徐々に分解され、最終的に二酸化炭素と水に変換されます。これにより、薬物を一定速度で放出することが可能です。 ナノ粒子系は、薬物をナノスケールの粒子に封入し、徐放性を持たせる手法です。この方法では、薬物が細胞の膜を透過する能力を高め、局所的な効果を発揮することが期待されます。ナノ粒子を利用することで、薬物の生物学的利用効率が向上し、治療効果の向上が図れます。 このような生体吸収性眼科用薬物送達システムは、様々な用途に適応可能です。まず、緑内障や眼圧上昇などの慢性疾患に対する治療が挙げられます。これらの疾患では長期にわたり薬物を投与する必要があり、持続的な薬物供給が求められます。生体吸収性材料を使用することで、薬物を持続的に放出できるため、患者の負担を軽減し、治療の遵守率も向上します。 また、網膜疾患や白内障手術後の治療、さらには角膜移植後の免疫抑制などの場面でも、生体吸収性眼科用薬物送達システムが利用されることがあります。例えば、網膜疾患においては、新しい治療薬の効果を最大限に引き出すために、効果的な薬物投与が必要です。このようなニーズに応えるため、長期間にわたって薬物を安定した濃度で放出するシステムが重要視されています。 関連技術としては、薬物の包接技術や修飾技術が挙げられます。これらの技術により、薬物の生物学的効果や安定性を向上させることができます。例えば、薬物をポリマーで包接することで、薬物が分解されるのを遅らせ、持続的な放出を実現することが可能です。また、薬物の化学構造を修飾することで、眼組織への親和性を高め、局所的な治療効果を発揮させることもできます。 最終的に、生体吸収性眼科用薬物送達システムは、今後の眼科治療において革新的な役割を果たすと期待されています。この技術は、患者にとっても医療提供者にとっても大きなメリットをもたらす可能性があり、さらなる研究と実用化が進めば、眼科領域の治療法が大きく変わるかもしれません。 生体吸収性眼科用薬物送達システムの発展により、慢性眼疾患や手術後の治療において、新たな治療法が実現されることが望まれます。患者のQOLの向上を図りつつ、医療全体の効率化につながることが期待されており、今後もこの分野の進展に注目が集まるでしょう。この技術が持つ可能性は無限であり、さらなる研究や開発が進むことで、将来的にはより多くの患者に恩恵をもたらすことが期待されます。 |